Executive Director
Takeda
Dr. Indranil Bhattacharya, PhD is currently an Executive Director, Quantitative Clinical Pharmacology leading Marketed Products Development and Global Regions at Takeda. Dr. Bhattacharya has experience applying clinical pharmacology and quantitative principles across the whole continuum of drug development; from discovery, preclinical, early to late clinical development; for different therapeutic areas (with a focus on inflammation and rare diseases) across different organizations ranging from small biotech to large pharma; encompassing different modalities. Dr. Bhattacharya received his PhD from State University of New York at Buffalo.
Exploring Expanded Access: Balancing Patient Needs and Regulatory Considerations
Thursday, May 29, 2025
9:30 AM - 10:30 AM East Coast USA Time